UDoTest
Empowering proactive health with early disease detection through accessible self-sampling screening.
Empowering proactive health with early disease detection through accessible self-sampling screening.
UDoTest is a B2B disease testing SaaS platform that aims to revolutionize proactive health by facilitating early disease detection through accessible self-sampling screening. The company, founded in 2017 by Allison Martin and based in Boston, Massachusetts, focuses on bridging screening gaps, enhancing the wellness experience, and improving quality through a human-centered approach. The platform's self-sampling test kits are tailored for conducting colon cancer and other health screenings, ultimately enabling early disease detection. In October 2020, MassChallenge made a Non-Equity Assistance investment in the company, indicating the confidence of investors in UDoTest's mission and potential within the Healthcare and SaaS industries. This demonstrates the company's ability to attract support from reputable sources as it continues to develop its innovative solution for proactive health management.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | Unknown | 1 |
|
21 Oct 2020 |
| Seed Round | Unknown | 1 |
|
01 Jan 2020 |
No recent news or press coverage available for UDoTest.
We care about your data, and we'd love to use cookies make your experience better.
